Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...

This paper is an initial attempt to shed new light on the nature and dynamics of technological agreements based on some cognitive dimensions. The main purpose of such agreements is to create new competencies, and therefore we argue that the nature and characteristics of the knowledge bases that...

This note discusses the medical/therapeutical responses to the COVID-19 pandemic and their “political economy” context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical exploitation. Such knowledge has largely...